ar tic le in pr es s primary antibodies against gnpnat1 (Cell Signaling Technology Inc)
86
Structured Review
Cell Signaling Technology Inc
ar tic le in pr es s primary antibodies against gnpnat1
Ar Tic Le In Pr Es S Primary Antibodies Against Gnpnat1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibodies+against+ar/pm41896862-52-3-32
Average 86 stars, based on 1 article reviews
Ar Tic Le In Pr Es S Primary Antibodies Against Gnpnat1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibodies+against+ar/pm41896862-52-3-32
Average 86 stars, based on 1 article reviews
ar tic le in pr es s primary antibodies against gnpnat1 - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
other:Article Title: Artesunate enhances the efficacy of enzalutamide in advanced prostate cancer Article Snippet: Antibodies against AR (5153), GAPDH (5174), cleaved-caspase 3 (9661), Ki67 (9027), PSA (5365), actin (3700), Article Title: GOLM1 promotes prostate cancer progression via interaction with PSMD1 and enhancing AR ‐driven transcriptional activation Article Snippet: Antibodies against AR, KLK3, Ub and Incubation:Article Title: Enzalutamide effectively inhibits the growth of meningiomas via p21-dependent senescence induction. Article Snippet: Meningiomas are the most common primary intracranial tumors, arising from the arachnoid cap cells of the meninges.. It accounts for approximately 38.3% of all central nervous system (CNS) tumors [1].. The majority are classified as World Health Organization (WHO) Grade 1, which is considered benign. Article Title: Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-TGF-β1 signaling mechanism Article Snippet: ChIP experiments were performed with the ChIP Assay Kit (#17-295, Merck Millipore, Germany) according to the manufacturers instructions. .. The samples were incubated with primary Western Blot:Article Title: The Transmembrane Protein TM4SF3 Interacts With AR and AR-V7 and is Recruited to AR Target Genes. Article Snippet: Prostate cancer transitions from an early treatable form to the lethal castration-resistant prostate cancer (CRPC).. Androgen receptor (AR) and constitutively active AR splice variants, such as AR-V7, may be major drivers of CRPC.. Our laboratory recently identified a novel mechanism of AR regulation via the transmembrane protein transmembrane 4 superfamily 3 (TM4SF3), which exhibits a physical interaction, nuclear colocalization, and mutual stabilization with AR. Immunoprecipitation:Article Title: Total Flavonoids of Hedyotis Diffusa Willd Suppresses Prostate Cancer Progression by Promoting AR Ubiquitination and Degradation via the PIAS4/STAT3 Pathway. Article Snippet: Total flavonoids of Hedyotis diffusa Willd (TFHDW) is an active compound extracted from Hedyotis diffusa Willd (HDW), one of the most well‐known herbs possessing antitumor effects.. In this study, the potential antitumor effects of TFHDW were investigated in vitro in mouse prostate cancer cells RM1 and human prostate cancer cells LNCaP and in vivo using a xenograft tumor model involving injection of RM1 cells.. Upon TFHDW treatment, RM1 and LNCaP cells exhibited augmented protein expression of the protein inhibitor of activated STAT (PIAS4) and diminished activity of signal transducer and activator of transcription 3 (STAT3), along with impaired proliferative, migratory, and invasive capacities. Control:Article Title: Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-TGF-β1 signaling mechanism Article Snippet: ChIP experiments were performed with the ChIP Assay Kit (#17-295, Merck Millipore, Germany) according to the manufacturers instructions. .. The samples were incubated with primary |